MedPath

Hormonal changes in women with excessive bleeding following delivery.

Not Applicable
Conditions
Health Condition 1: O720- Third-stage hemorrhage
Registration Number
CTRI/2020/07/026653
Lead Sponsor
Maulana Azad Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Postpartum women with any of the following:

1.Postpartum hemorrhage after normal vaginal delivery: >1000ml blood loss

2.Postpartum hemorrhage after cesarean section: >1500ml blood loss

3.Shock grade III & IV

4.Requiring hysterectomy for hemorrhage

5.Fall in hemoglobin >= 3g/dl due to hemorrhagic event

Exclusion Criteria

Postpartum women with known diagnosis of or clinically suspected to have any of the following condition:

1.Patient on corticosteroid therapy

2.Patient with known thyroid disease

3.Patient with adrenal abnormalities

4.Patient with pituitary malfunction

5.Patient with active tuberculosis

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess for the circulating levels of anterior pituitary hormones and clinical signs of hypopituitarism in women experiencing postpartum hemorrhageTimepoint: 1.Within 7 days of delivery <br/ ><br>2.At 14 weeks after delivery <br/ ><br>3.At 24 weeks after delivery
Secondary Outcome Measures
NameTimeMethod
To assess for lactational dysfunction in women experiencing postpartum hemorrhageTimepoint: 1.Within 7 days of delivery <br/ ><br>2.At 14 weeks after delivery <br/ ><br>3.At 24 weeks after delivery
© Copyright 2025. All Rights Reserved by MedPath